Home LiteratureArticle Details
PMID: 7798324 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage.

The Journal of cell biology ·Vol. 127 ·No. 6 Pt 1 ·1994-12-00 ·Pages 1755-66

Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T

Abstract

The implantation of bone morphogenetic protein (BMP) into muscular tissues induces ectopic bone formation at the site of implantation. To investigate the mechanism underlying this process, we examined whether recombinant bone morphogenetic protein-2 (BMP-2) converts the differentiation pathway of the clonal myoblastic cell line, C2C12, into that of osteoblast lineage. Incubating the cells with 300 ng/ml of BMP-2 for 6 d almost completely inhibited the formation of the multinucleated myotubes expressing troponin T and myosin heavy chain, and induced the appearance of numerous alkaline phosphatase (ALP)-positive cells. BMP-2 dose dependently induced ALP activity, parathyroid hormone (PTH)-dependent 3',5'-cAMP production, and osteocalcin production at concentrations above 100 ng/ml. The concentration of BMP-2 required to induce these osteoblastic phenotypes was the same as that required to almost completely inhibit myotube formation. Incubating primary muscle cells with 300 ng/ml of BMP-2 for 6 d also inhibited myotube formation, whereas induced ALP activity and osteocalcin production. Incubation with 300 ng/ml of BMP-2 suppressed the expression of mRNA for muscle creatine kinase within 6 h, whereas it induced mRNA expression for ALP, PTH/PTH-related protein (PTHrP) receptors, and osteocalcin within 24-48 h. BMP-2 completely inhibited the expression of myogenin mRNA by day 3. By day 3, BMP-2 also inhibited the expression of MyoD mRNA, but it was transiently stimulated 12 h after exposure to BMP-2. Expression of Id-1 mRNA was greatly stimulated by BMP-2. When C2C12 cells pretreated with BMP-2 for 6 d were transferred to a colony assay system in the absence of BMP-2, more than 84% of the colonies generated became troponin T-positive and ALP activity disappeared. TGF-beta 1 also inhibited myotube formation in C2C12 cells, and suppressed the expression of myogenin and MyoD mRNAs without inducing that of Id-1 mRNA. However, no osteoblastic phenotype was induced by TGF-beta 1 in C2C12 cells. TGF-beta 1 potentiated the inhibitory effect of BMP-2 on myotube formation, whereas TGF-beta 1 reduced ALP activity and osteocalcin production induced by BMP-2 in C2C12 cells. These results indicate that BMP-2 specifically converts the differentiation pathway of C2C12 myoblasts into that of osteoblast lineage cells, but that the conversion is not heritable.

MeSH Terms
Alkaline Phosphatase/biosynthesis Animals Bone Development/physiology Bone Morphogenetic Proteins Cell Differentiation/drug effects Creatine Kinase/biosynthesis Cyclic AMP/biosynthesis DNA-Binding Proteins/biosynthesis,genetics Dose-Response Relationship, Drug Helix-Loop-Helix Motifs Inhibitor of Differentiation Protein 1 Mice Muscles/cytology,drug effects,embryology MyoD Protein/biosynthesis,genetics Myogenin/biosynthesis,genetics Osteoblasts/physiology Osteocalcin/biosynthesis Parathyroid Hormone/biosynthesis Phenotype Proteins/pharmacology RNA, Messenger/analysis Repressor Proteins Stem Cells/drug effects Time Factors Transcription Factors Transforming Growth Factor beta/pharmacology
Chemicals
Bone Morphogenetic Proteins DNA-Binding Proteins Idb1 protein, mouse Inhibitor of Differentiation Protein 1 MyoD Protein Myog protein, mouse Myogenin Parathyroid Hormone Proteins RNA, Messenger Repressor Proteins Transcription Factors Transforming Growth Factor beta Osteocalcin Cyclic AMP Creatine Kinase Alkaline Phosphatase
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Katagiri T
Department of Biochemistry, Showa University, Tokyo, Japan.
Yamaguchi A
Komaki M
Abe E
Takahashi N
Ikeda T
Rosen V
Wozney J M
Fujisawa-Sehara A
Suda T
References (84)
84 references, click to expand
  1. Expression of multiple troponin T variants in neonatal chicken breast muscle.
    Dev Biol. 1986 Nov;118(1):42-51 PMID: 3770307
  2. Type beta transforming growth factor is an inhibitor of myogenic differentiation.
    Proc Natl Acad Sci U S A. 1986 Nov;83(21):8206-10 PMID: 3022285
  3. Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells.
    Biochem Biophys Res Commun. 1986 Oct 15;140(1):56-65 PMID: 3465325
  4. Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells.
    J Biol Chem. 1986 Dec 15;261(35):16509-13 PMID: 3465726
  5. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
    Anal Biochem. 1987 Apr;162(1):156-9 PMID: 2440339
  6. Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor.
    J Cell Biol. 1987 Aug;105(2):949-56 PMID: 3624313
  7. Inhibition of myogenic differentiation by fibroblast growth factor or type beta transforming growth factor does not require persistent c-myc expression.
    Dev Biol. 1987 Oct;123(2):500-7 PMID: 3477514
  8. Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography.
    Proc Natl Acad Sci U S A. 1987 Oct;84(20):7109-13 PMID: 3478684
  9. Expression of a single transfected cDNA converts fibroblasts to myoblasts.
    Cell. 1987 Dec 24;51(6):987-1000 PMID: 3690668
  10. Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro.
    J Cell Physiol. 1988 Mar;134(3):337-46 PMID: 3162457
  11. Transforming growth factor-beta reduces the phenotypic expression of osteoblastic MC3T3-E1 cells in monolayer culture.
    Bone. 1987;8(4):259-62 PMID: 2833296
  12. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone.
    J Cell Biol. 1988 Jun;106(6):2139-51 PMID: 3384856
  13. cDNA cloning of alkaline phosphatase from rat osteosarcoma (ROS 17/2.8) cells.
    J Bone Miner Res. 1987 Apr;2(2):161-4 PMID: 3484182
  14. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts.
    Science. 1988 Oct 21;242(4877):405-11 PMID: 3175662
  15. Purification and characterization of other distinct bone-inducing factors.
    Proc Natl Acad Sci U S A. 1988 Dec;85(24):9484-8 PMID: 3200834
  16. Novel regulators of bone formation: molecular clones and activities.
    Science. 1988 Dec 16;242(4885):1528-34 PMID: 3201241
  17. Transcriptional regulation of osteocalcin production by transforming growth factor-beta in rat osteoblast-like cells.
    Endocrinology. 1989 Feb;124(2):612-7 PMID: 2783570
  18. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD.
    Cell. 1989 Feb 24;56(4):607-17 PMID: 2537150
  19. Muscle basic helix-loop-helix proteins and the regulation of myogenesis.
    Curr Opin Genet Dev. 1992 Apr;2(2):243-8 PMID: 1638118
  20. Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins.
    Genes Dev. 1992 Aug;6(8):1466-79 PMID: 1644289
  21. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death.
    Cell. 1992 Oct 30;71(3):369-82 PMID: 1423602
  22. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development.
    Cell. 1992 Oct 30;71(3):383-90 PMID: 1330322
  23. Myogenic cell lineages.
    Dev Biol. 1992 Dec;154(2):284-98 PMID: 1426639
  24. Expression of helix-loop-helix regulatory genes during differentiation of mouse osteoblastic cells.
    J Bone Miner Res. 1992 Oct;7(10):1131-8 PMID: 1280901
  25. Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis.
    J Biol Chem. 1992 Dec 15;267(35):25220-7 PMID: 1460021
  26. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains.
    Cell. 1992 Dec 24;71(7):1181-94 PMID: 1335366
  27. Helix-loop-helix proteins as regulators of muscle-specific transcription.
    J Biol Chem. 1993 Jan 15;268(2):755-8 PMID: 8380414
  28. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene.
    Nature. 1993 Aug 5;364(6437):501-6 PMID: 8393145
  29. Myogenin gene disruption results in perinatal lethality because of severe muscle defect.
    Nature. 1993 Aug 5;364(6437):532-5 PMID: 8393146
  30. Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of a conserved threonine residue within the DNA-binding domain.
    Mol Cell Biol. 1993 Oct;13(10):5943-56 PMID: 8413199
  31. Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells.
    Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9219-22 PMID: 8415680
  32. Bone morphogenetic protein inhibits differentiation and affects expression of helix-loop-helix regulatory molecules in myoblastic cells.
    J Cell Biochem. 1993 Sep;53(1):51-60 PMID: 7693731
  33. The MyoD family and myogenesis: redundancy, networks, and thresholds.
    Cell. 1993 Dec 31;75(7):1241-4 PMID: 8269506
  34. MyoD or Myf-5 is required for the formation of skeletal muscle.
    Cell. 1993 Dec 31;75(7):1351-9 PMID: 8269513
  35. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts.
    J Biol Chem. 1994 Jan 21;269(3):2139-45 PMID: 8294468
  36. Bone: formation by autoinduction.
    Science. 1965 Nov 12;150(3698):893-9 PMID: 5319761
  37. Cultivation in vitro of cells derived from a human osteosarcoma.
    Cancer. 1971 Feb;27(2):397-402 PMID: 5100401
  38. Bone morphogenetic protein.
    J Dent Res. 1971 Nov-Dec;50(6):1392-406 PMID: 4943222
  39. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.
    Cell. 1989 Mar 10;56(5):777-83 PMID: 2493990
  40. In vivo stimulation of bone formation by transforming growth factor-beta.
    Endocrinology. 1989 Jun;124(6):2991-4 PMID: 2721454
  41. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts.
    EMBO J. 1989 Mar;8(3):701-9 PMID: 2721498
  42. Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo.
    J Cell Physiol. 1989 Jul;140(1):1-7 PMID: 2544612
  43. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program.
    Genes Dev. 1989 May;3(5):628-40 PMID: 2473006
  44. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.
    Cell. 1989 Aug 11;58(3):537-44 PMID: 2503252
  45. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation.
    J Biol Chem. 1989 Aug 15;264(23):13377-80 PMID: 2547759
  46. Recombinant human bone morphogenetic protein induces bone formation.
    Proc Natl Acad Sci U S A. 1990 Mar;87(6):2220-4 PMID: 2315314
  47. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins.
    Cell. 1990 Apr 6;61(1):49-59 PMID: 2156629
  48. Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor.
    J Biol Chem. 1990 Apr 15;265(11):5960-3 PMID: 1690720
  49. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur.
    J Cell Biol. 1990 Jun;110(6):2195-207 PMID: 2351696
  50. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family.
    EMBO J. 1990 Jul;9(7):2085-93 PMID: 2357959
  51. Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization.
    Genes Dev. 1990 Apr;4(4):582-95 PMID: 2163343
  52. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily.
    J Biol Chem. 1990 Aug 5;265(22):13198-205 PMID: 2376592
  53. Myogenin contains two domains conserved among myogenic factors.
    J Biol Chem. 1990 Sep 5;265(25):15219-23 PMID: 2168405
  54. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2.
    Biochem Biophys Res Commun. 1990 Oct 15;172(1):295-9 PMID: 1699539
  55. MyoD family: a paradigm for development?
    Genes Dev. 1990 Sep;4(9):1454-61 PMID: 2253873
  56. Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell line.
    Dev Biol. 1990 Dec;142(2):313-8 PMID: 2257970
  57. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone.
    Proc Natl Acad Sci U S A. 1990 Dec;87(24):9843-7 PMID: 2263636
  58. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1.
    Biochem Biophys Res Commun. 1991 Jan 15;174(1):96-101 PMID: 1989624
  59. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer.
    Cell. 1989 Sep 8;58(5):823-31 PMID: 2550138
  60. Fibroblast growth factor and transforming growth factor beta repress transcription of the myogenic regulatory gene MyoD1.
    Mol Cell Biol. 1989 Aug;9(8):3576-9 PMID: 2797000
  61. Marrow stromal stem cells.
    J Cell Sci Suppl. 1988;10:63-76 PMID: 3077943
  62. Herculin, a fourth member of the MyoD family of myogenic regulatory genes.
    Proc Natl Acad Sci U S A. 1990 Feb;87(3):1089-93 PMID: 2300571
  63. Properties and origin of osteoblasts.
    Clin Orthop Relat Res. 1990 Mar;(252):276-93 PMID: 2154350
  64. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation.
    Cell. 1990 Mar 9;60(5):733-46 PMID: 2155707
  65. Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12.
    EMBO J. 1990 Mar;9(3):821-31 PMID: 2311584
  66. Identification of MRF4: a new member of the muscle regulatory factor gene family.
    Genes Dev. 1989 Dec;3(12B):2050-61 PMID: 2560751
  67. The myoD gene family: nodal point during specification of the muscle cell lineage.
    Science. 1991 Feb 15;251(4995):761-6 PMID: 1846704
  68. Transforming growth factor-beta modulates proliferation and differentiation of mouse clonal osteoblastic MC3T3-E1 cells depending on their maturation stages.
    Bone Miner. 1990 Dec;11(3):285-93 PMID: 2085682
  69. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro.
    J Cell Biol. 1991 May;113(3):681-7 PMID: 1849907
  70. Transforming growth factor beta represses the actions of myogenin through a mechanism independent of DNA binding.
    Proc Natl Acad Sci U S A. 1991 May 1;88(9):3822-6 PMID: 1850837
  71. Clonal osteogenic cell lines express myogenic and adipocytic developmental potential.
    Calcif Tissue Int. 1991 Sep;49(3):221-5 PMID: 1657329
  72. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide.
    Science. 1991 Nov 15;254(5034):1024-6 PMID: 1658941
  73. Id gene expression and its suppression by 1,25-dihydroxyvitamin D3 in rat osteoblastic osteosarcoma cells.
    Proc Natl Acad Sci U S A. 1992 May 15;89(10):4569-72 PMID: 1584793
  74. Repression of myogenin function by TGF-beta 1 is targeted at the basic helix-loop-helix motif and is independent of E2A products.
    J Biol Chem. 1992 Jun 5;267(16):10956-60 PMID: 1317849
  75. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle.
    Nature. 1977 Dec 22-29;270(5639):725-7 PMID: 563524
  76. In vitro cultivation of human tumor tissues. II. Morphological and virological characterization of three cell lines.
    Oncology. 1978;35(6):246-52 PMID: 218153
  77. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine.
    Cell. 1979 Aug;17(4):771-9 PMID: 90553
  78. Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma.
    Endocrinology. 1980 Nov;107(5):1494-503 PMID: 6968673
  79. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro.
    J Cell Biol. 1982 Dec;95(3):763-70 PMID: 6185504
  80. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria.
    J Cell Biol. 1983 Jan;96(1):191-8 PMID: 6826647
  81. Cytoplasmic activation of human nuclear genes in stable heterocaryons.
    Cell. 1983 Apr;32(4):1171-80 PMID: 6839359
  82. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin.
    Cancer Res. 1983 Sep;43(9):4308-14 PMID: 6575864
  83. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation.
    J Biol Chem. 1986 Jul 15;261(20):9483-8 PMID: 3722206
  84. Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones.
    EMBO J. 1986 Aug;5(8):1885-90 PMID: 3019668
Article Info
Journal
The Journal of cell biology
Abbr.
J Cell Biol
ISSN
0021-9525
Published
1994-12-00
Pages
1755-66
Language
English
Region
United States
NLM ID
0375356
PMCID
PMC2120318
Subset
IM
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com